Advanced Search
FANG Qiang, HUANG Jianming, WANG Kangning, ZHOU Hong, HAN Yongtao. Characteristics of Laboratory Biomarkers Associated with Hypercoagulability in Lung Cancer Patients During Perioperative Period and Its Diagnostic Value for Deep Venous Thrombosis[J]. Cancer Research on Prevention and Treatment, 2019, 46(12): 1107-1112. DOI: 10.3971/j.issn.1000-8578.2019.19.0591
Citation: FANG Qiang, HUANG Jianming, WANG Kangning, ZHOU Hong, HAN Yongtao. Characteristics of Laboratory Biomarkers Associated with Hypercoagulability in Lung Cancer Patients During Perioperative Period and Its Diagnostic Value for Deep Venous Thrombosis[J]. Cancer Research on Prevention and Treatment, 2019, 46(12): 1107-1112. DOI: 10.3971/j.issn.1000-8578.2019.19.0591

Characteristics of Laboratory Biomarkers Associated with Hypercoagulability in Lung Cancer Patients During Perioperative Period and Its Diagnostic Value for Deep Venous Thrombosis

More Information
  • Corresponding author:

    HAN Yongtao, E-mail:hanyongt@aliyun.com

  • Received Date: May 06, 2019
  • Revised Date: October 16, 2019
  • Available Online: January 12, 2024
  • Objective 

    To analyze the characteristics of laboratory biomarkers associated with hypercoagulability in patients undergoing lung cancer surgery during the perioperative period and its diagnostic value for deep venous thrombosis (DVT).

    Methods 

    We enrolled 143 patients treated with lung cancer surgery based on eligibility criteria. The lower extremity deep vein was examined perioperatively by compressed ultrasonic (CUS) to determine the DVT. The laboratory biomarkers associated with hypercoagulability were measured. We analyzed the area under curve (AUC) of ROC and cutoff in DVT (+) and DVT (-) groups with significant different biomarkers.

    Results 

    Thirty-three patients with DVT were first diagnosed from the postoperative 3rd day (POD3) to 7th day (POD7). The fibrinogen degradation product (FDP), D-Dimer, brain natriuretic peptide and C reactive protein were significantly increased in the postoperative POD1-POD7 (P < 0.05). There were significant differences in the change levels of FDP and D-D during the perioperative period between the DVT (+) and DVT (-) groups (P < 0.05). The AUC and diagnostic cutoff values of POD1-FDP, POD3-FDP, POD3-D-D were 0.726 and 4.65μg/ml, 0.811 and 4.85 μg/ml, 0.772 and 1.55 μg/ml, respectively. The sensitivity and specificity of serial test were 46.5% and 94.9% for the combined diagnosis.

    Conclusion 

    The value of increased levels of POD1-FDP, POD3-FDP and POD3-D-Dimer for DVT diagnosis is moderate. The combined diagnosis with serial test could improve the specificity of diagnosis.

  • [1]
    Wang Z, Pei C, Ma L, et al. Acute pulmonary embolism after pneumonectomy[J]. J Thoracic Dis, 2012, 4(1): 76-82. http://d.old.wanfangdata.com.cn/Periodical/jrfsxzz200912010
    [2]
    Hwang HG, Schulman S. Respiratory review of 2013: pulmonary thromboembolism[J]. Tuberc Respir Dis(Seoul), 2013, 75(3): 89-94. doi: 10.4046/trd.2013.75.3.89
    [3]
    崔松平, 李辉, 田博, 等.肺癌术后静脉血栓栓塞症相关危险因素分析:单中心研究[J].中国肺癌杂志, 2018, 21(10): 753-760. doi: 10.3779/j.issn.1009-3419.2018.10.04

    Cui SP, Li H, Tian B, et al. Risk Factors Associated with Venous Thromboembolism after Lung Cancer Surgery:A Single-center Study[J]. Zhongguo Fei Ai Za Zhi, 2018, 21(10): 753-760. doi: 10.3779/j.issn.1009-3419.2018.10.04
    [4]
    Yang Y, Zhou Z, Niu XM, et al. Clinical analysis of postoperative venous thromboembolism risk factors in lung cancer patients[J]. J Surg Oncol, 2012, 106(6): 736-741. doi: 10.1002/jso.23190
    [5]
    Pabinger I, Thaler J, Ay C. Biomarkers for prediction of venous thromboembolism in cancer[J]. Blood, 2013, 122(12): 2011-2018. doi: 10.1182/blood-2013-04-460147
    [6]
    刘振华, 崔同建, 陈峥, 等.恶性肿瘤并发深静脉血栓形成33例诊治分析[J].肿瘤防治研究, 2012, 39(5): 570-572. doi: 10.3971/j.issn.1000-8578.2012.05.019

    Liu ZH, Cui TJ, Chen Z, et al. Clinical study on 33 cases of malignant tumor complicated with venous thrombotic embolism[J]. Zhong Liu Fang Zhi Yan Jiu, 2012, 39(5): 570-572. doi: 10.3971/j.issn.1000-8578.2012.05.019
    [7]
    Alexander M, Burbury K. A systematic review of biomarkers for the prediction of thromboembolism in lung cancer-Results, practical issues and proposed strategies for future risk prediction models[J]. Thromb Res, 2016, 148: 63-69. doi: 10.1016/j.thromres.2016.10.020
    [8]
    Vitale C, D'Amato M, Calabrò P, et al. Venous thromboembolism and lung cancer: a review[J]. Multidiscip Respir Med, 2015, 10(1): 28. doi: 10.1186/s40248-015-0021-4
    [9]
    Ghozlan MF, Osman AA, Mahmoud HM, et al. Comprehensive study on laboratory biomarkers for prediction and diagnosis of deep venous thrombosis[J]. Blood Coagulation Fibrinolysis, 2015, 26(3): 255-260. doi: 10.1097/MBC.0000000000000164
    [10]
    Kadlec B, Skrickova J, Merta Z, et al. The incidence and predictors of thromboembolic events in patients with lung cancer[J]. Scientific World J, 2014, 2014: 125706. http://cn.bing.com/academic/profile?id=5425b88276a6608abdd4f792c383a654&encoded=0&v=paper_preview&mkt=zh-cn
    [11]
    Tian B, Song C, Li H, et al. The significance of perioperative coagulation and fibrinolysis related parameters after lung surgery for predicting venous thromboembolism: a prospective, single center study[J]. J Thorac Dis, 2018, 10(4): 2223-2230. doi: 10.21037/jtd.2018.03.174
    [12]
    van Es N, Kraaijpoel N, Klok FA, et al. The original and simplifiedWellsrules and age-adjustedD-dimertesting to rule out pulmonary embolism: an individual patient data meta-analysis[J]. J Thromb Haemost, 2017, 15(4): 678-684. doi: 10.1111/jth.13630
    [13]
    Mousa AY, Broce M, De Wit D, et al. Appropriate Use ofVenousImaging and Analysis of theD-Dimer/Clinical Probability Testing Paradigm in the Diagnosis and Location ofDeep Venous Thrombosis[J]. Ann Vasc Surg, 2018, 50: 21-29. doi: 10.1016/j.avsg.2017.12.006
    [14]
    Pabinger I, van Es N, Heinze G, et al. A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts[J]. Lancet Haematol, 2018, 5(7): e289-e298. doi: 10.1016/S2352-3026(18)30063-2
    [15]
    赵灿, 胡京敏, 赵丹杰.血浆D-二聚体临界值联合Wells量表对可疑肺栓塞的除外价值[J].北京大学学报(医学版), 2018, 50(5): 828-832. http://d.old.wanfangdata.com.cn/Periodical/bjykdxxx201805011

    Zhao C, Hu JM, Guo DJ. Diagnostic value of D-dimer combined with Wells score for suspected pulmonary embolism[J]. Beijing Da Xue Xue Bao(Yi Xue Ban), 2018, 50(5): 828-832. http://d.old.wanfangdata.com.cn/Periodical/bjykdxxx201805011
    [16]
    Ay C, Vormittag R, Dunkler D, et al. D-Dimer and Prothrombin Fragment 1+2 Predict Venous Thromboembolism in Patients With Cancer: Results From the Vienna Cancer and Thrombosis Study[J]. J Clin Oncol, 2009, 27(25): 4124-4129. doi: 10.1200/JCO.2008.21.7752
    [17]
    万静萱, 李红红, 杨叶梦, 等.血浆D-二聚体诊断肺癌合并肺栓塞的最佳临界值研究[J].中国全科医学, 2018, 21(10): 1212-1215. doi: 10.3969/j.issn.1007-9572.2018.10.014

    Wan JX, Li HH, YangYM, et al.Optimal Cut-off Value of Plasma D-dimer in the Diagnosis of Pulmonary Embolism in Lung Cancer Patients[J]. Zhongguo Quan Ke Yi Xue, 2018, 21(10): 1212-1216. doi: 10.3969/j.issn.1007-9572.2018.10.014
    [18]
    Jara-Palomares L, Solier-Lopez A, Elias-Hernandez T, et al. D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis[J]. Br J Cancer, 2018, 119(8): 915-921. doi: 10.1038/s41416-018-0269-5

Catalog

    Article views (1319) PDF downloads (389) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return